BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34064193)

  • 1. Oncolytic Vaccinia Virus Expressing White-Spotted Charr Lectin Regulates Antiviral Response in Tumor Cells and Inhibits Tumor Growth In Vitro and In Vivo.
    Wang X; Zhou N; Liu T; Jia X; Ye T; Chen K; Li G
    Mar Drugs; 2021 May; 19(6):. PubMed ID: 34064193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic Vaccinia Virus Expressing
    Wu T; Xiang Y; Liu T; Wang X; Ren X; Ye T; Li G
    Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31248066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins on Hepatocellular Carcinoma Cells.
    Zhou Y; Wang Q; Ying Q; Zhang X; Chen K; Ye T; Li G
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparative Study of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins in Breast Cancer Cells.
    Zhou Y; Wang Q; Ying Q; Zhang X; Ye T; Chen K; Li G
    Mar Drugs; 2023 Jan; 21(2):. PubMed ID: 36827118
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Li G; Cheng J; Mei S; Wu T; Ye T
    Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29880736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic Vaccinia Virus Harboring
    Jiang R; Qiu Y; Zhang X; Zhou N; Jia X; Chen K; Zhou Y; Ye T; Li G
    Mar Drugs; 2022 Jun; 20(6):. PubMed ID: 35736181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic Vaccinia Virus Carrying
    Zheng X; Xu W; Ying Q; Ni J; Jia X; Zhou Y; Ye T; Li G; Chen K
    Mar Drugs; 2022 Oct; 20(11):. PubMed ID: 36354990
    [No Abstract]   [Full Text] [Related]  

  • 8.
    Li G; Mei S; Cheng J; Wu T; Luo J
    Mar Drugs; 2018 Apr; 16(5):. PubMed ID: 29701680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic Vaccinia Virus Harboring
    Ni J; Feng H; Xu X; Liu T; Ye T; Chen K; Li G
    Mar Drugs; 2021 Sep; 19(10):. PubMed ID: 34677432
    [No Abstract]   [Full Text] [Related]  

  • 10. Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.
    Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B
    Oncotarget; 2017 Jun; 8(25):40533-40543. PubMed ID: 28465492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
    Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
    PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of the B18R gene of vaccinia virus into an oncolytic herpes simplex virus improves antitumor activity.
    Fu X; Rivera A; Tao L; Zhang X
    Mol Ther; 2012 Oct; 20(10):1871-81. PubMed ID: 22692498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteolin enhances the antitumor efficacy of oncolytic vaccinia virus that harbors IL-24 gene in liver cancer cells.
    Wang C; Li Q; Xiao B; Fang H; Huang B; Huang F; Wang Y
    J Clin Lab Anal; 2021 Mar; 35(3):e23677. PubMed ID: 33274495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An oncolytic vaccinia virus armed with anti-human-PD-1 antibody and anti-human-4-1BB antibody double genes for cancer-targeted therapy.
    Shi Z; Liu B; Huang C; Xie W; Cen Y; Chen L; Liang M
    Biochem Biophys Res Commun; 2021 Jun; 559():176-182. PubMed ID: 33945995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.
    Chen NG; Yu YA; Zhang Q; Szalay AA
    J Transl Med; 2011 Sep; 9():164. PubMed ID: 21951588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lister vaccine strain of vaccinia virus armed with the endostatin-angiostatin fusion gene: an oncolytic virus superior to dl1520 (ONYX-015) for human head and neck cancer.
    Tysome JR; Wang P; Alusi G; Briat A; Gangeswaran R; Wang J; Bhakta V; Fodor I; Lemoine NR; Wang Y
    Hum Gene Ther; 2011 Sep; 22(9):1101-8. PubMed ID: 21361787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a new recombinant oncolytic vaccinia virus strain GLV-5b451 for feline mammary carcinoma therapy.
    Adelfinger M; Gentschev I; Grimm de Guibert J; Weibel S; Langbein-Laugwitz J; Härtl B; Murua Escobar H; Nolte I; Chen NG; Aguilar RJ; Yu YA; Zhang Q; Frentzen A; Szalay AA
    PLoS One; 2014; 9(8):e104337. PubMed ID: 25093734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation.
    Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL
    Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846
    [No Abstract]   [Full Text] [Related]  

  • 19. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.
    Deng L; Fan J; Guo M; Huang B
    Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus.
    Dong F; Wang L; Davis JJ; Hu W; Zhang L; Guo W; Teraishi F; Ji L; Fang B
    Clin Cancer Res; 2006 Sep; 12(17):5224-30. PubMed ID: 16951242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.